124 related articles for article (PubMed ID: 20103677)
1. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.
Braconi C; Valeri N; Gasparini P; Huang N; Taccioli C; Nuovo G; Suzuki T; Croce CM; Patel T
Clin Cancer Res; 2010 Feb; 16(3):957-66. PubMed ID: 20103677
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
Bai S; Nasser MW; Wang B; Hsu SH; Datta J; Kutay H; Yadav A; Nuovo G; Kumar P; Ghoshal K
J Biol Chem; 2009 Nov; 284(46):32015-27. PubMed ID: 19726678
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination.
Lazarus JV; Picchio CA; Colombo M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762706
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response.
He P; Wan H; Wan J; Jiang H; Yang Y; Xie K; Wu H
Front Oncol; 2022; 12():1015527. PubMed ID: 36483039
[TBL] [Abstract][Full Text] [Related]
5. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma.
Alqahtani SA; Colombo M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831314
[TBL] [Abstract][Full Text] [Related]
6. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.
Carotenuto P; Amato F; Lampis A; Rae C; Hedayat S; Previdi MC; Zito D; Raj M; Guzzardo V; Sclafani F; Lanese A; Parisi C; Vicentini C; Said-Huntingford I; Hahne JC; Hallsworth A; Kirkin V; Young K; Begum R; Wotherspoon A; Kouvelakis K; Azevedo SX; Michalarea V; Upstill-Goddard R; Rao S; Watkins D; Starling N; Sadanandam A; Chang DK; Biankin AV; Jamieson NB; Scarpa A; Cunningham D; Chau I; Workman P; Fassan M; Valeri N; Braconi C
Nat Commun; 2021 Nov; 12(1):6738. PubMed ID: 34795259
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV.
De Matteis S; Ghetti M; Gramantieri L; Marisi G; Casadei-Gardini A
Onco Targets Ther; 2021; 14():4305-4308. PubMed ID: 34366674
[TBL] [Abstract][Full Text] [Related]
8. Cell death pathways and viruses: Role of microRNAs.
Sadri Nahand J; Shojaie L; Akhlagh SA; Ebrahimi MS; Mirzaei HR; Bannazadeh Baghi H; Mahjoubin-Tehran M; Rezaei N; Hamblin MR; Tajiknia V; Rahimian N; Mirzaei H
Mol Ther Nucleic Acids; 2021 Jun; 24():487-511. PubMed ID: 33898103
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors.
Angerilli V; Galuppini F; Businello G; Dal Santo L; Savarino E; Realdon S; Guzzardo V; Nicolè L; Lazzarin V; Lonardi S; Loupakis F; Fassan M
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33801049
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients.
Cabral BCA; Hoffmann L; Bottaro T; Costa PF; Ramos ALA; Coelho HSM; Villela-Nogueira CA; Ürményi TP; Faffe DS; Silva R
Biochem Biophys Rep; 2020 Dec; 24():100814. PubMed ID: 33015376
[TBL] [Abstract][Full Text] [Related]
11. A novel microRNA boosts hyper-β-oxidation of fatty acids in liver by impeding CEP350-mediated sequestration of PPARα and thus restricts chronic hepatitis C.
Ghosh S; Chakraborty J; Goswami A; Bhowmik S; Roy S; Ghosh A; Dokania S; Kumari P; Datta S; Chowdhury A; Bhattacharyya SN; Chatterjee R; Banerjee S
RNA Biol; 2020 Sep; 17(9):1352-1363. PubMed ID: 32507013
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-221 inhibits human papillomavirus 16 E1-E2 mediated DNA replication through activating SOCS1/Type I IFN signaling pathway.
Lu H; Gu X
Int J Clin Exp Pathol; 2019; 12(5):1518-1528. PubMed ID: 31933969
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.
Carotenuto P; Hedayat S; Fassan M; Cardinale V; Lampis A; Guzzardo V; Vicentini C; Scarpa A; Cascione L; Costantini D; Carpino G; Alvaro D; Ghidini M; Trevisani F; Te Poele R; Salati M; Ventura S; Vlachogiannis G; Hahne JC; Boulter L; Forbes SJ; Guest RV; Cillo U; Said-Huntingford I; Begum R; Smyth E; Michalarea V; Cunningham D; Rimassa L; Santoro A; Roncalli M; Kirkin V; Clarke P; Workman P; Valeri N; Braconi C
Hepatology; 2020 Sep; 72(3):982-996. PubMed ID: 31879968
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
Front Oncol; 2019; 9():1156. PubMed ID: 31750247
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status.
Lee SW; Lee TY; Peng YC; Yang SS; Yeh HZ; Chang CS
Medicine (Baltimore); 2019 Nov; 98(44):e17692. PubMed ID: 31689794
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
[TBL] [Abstract][Full Text] [Related]
18. Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Ali LH; Higazi AM; Moness HM; Farag NM; Saad ZM; Moukareb HA; Soliman W; El Sagheer G; Abd El Hamid SR; Abdl Hamid H
Clin Exp Gastroenterol; 2019; 12():51-66. PubMed ID: 30774409
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk mechanisms between the WNT signaling pathway and long non-coding RNAs.
Zarkou V; Galaras A; Giakountis A; Hatzis P
Noncoding RNA Res; 2018 Jun; 3(2):42-53. PubMed ID: 30159439
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours.
Ghidini M; Hahne JC; Frizziero M; Tomasello G; Trevisani F; Lampis A; Passalacqua R; Valeri N
Target Oncol; 2018 Aug; 13(4):423-436. PubMed ID: 30006826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
